CoChat

ADHD Pharmacotherapy and Mortality in Individuals With ADHD

Open access
Li, Lin, Zhu, Nanbo, Zhang, Le, Kuja-Halkola, Ralf, D’Onofrio, Brian M., Brikell, Isabell, Lichtenstein, Paul, Cortese, Samuele, Larsson, Henrik, Chang, Zheng · 2024 · JAMA
Cited by 124

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Importance: Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks of adverse health outcomes including premature death, but it is unclear whether ADHD pharmacotherapy influences the mortality risk. Objective: To investigate whether initiation of ADHD pharmacotherapy was associated with reduced mortality risk in individuals with ADHD. Design, Setting, and Participants: In an observational nationwide cohort study in Sweden applying the target trial emulation framework, we identified individuals aged 6 through 64 years with an incident diagnosis of ADHD from 2007 through 2018 and no ADHD medication dispensation prior to diagnosis. Follow-up started from ADHD diagnosis until death, emigration, 2 years after ADHD diagnosis, or December 31, 2020, whichever came first. Exposures: ADHD medication initiation was defined as dispensing of medication within 3 months of diagnosis. Main Outcomes and Measures: We assessed all-cause mortality within 2 years of ADHD diagnosis, as well as natural-cause (eg, physical conditions) and unnatural-cause mortality (eg, unintentional injuries, suicide, and accidental poisonings). Results: Of 148 578 individuals with ADHD (61 356 females [41.3%]), 84 204 (56.7%) initiated ADHD medication. The median age at diagnosis was 17.4 years (IQR, 11.6-29.1 years). The 2-year mortality risk was lower in the initiation treatment strategy group (39.1 per 10 000 individuals) than in the noninitiation treatment strategy group (48.1 per 10 000 individuals), with a risk difference of −8.9 per 10 000 individuals (95% CI, −17.3 to −0.6). ADHD medication initiation was associated with significantly lower rate of all-cause mortality (hazard ratio [HR], 0.79; 95% CI, 0.70 to 0.88) and unnatural-cause mortality (2-year mortality risk, 25.9 per 10 000 individuals vs 33.3 per 10 000 individuals; risk difference, −7.4 per 10 000 individuals; 95% CI, −14.2 to −0.5; HR, 0.75; 95% CI, 0.66 to 0.86), but not natural-cause mortality (2-year mortality risk, 13.1 per 10 000 individuals vs 14.7 per 10 000 individuals; risk difference, −1.6 per 10 000 individuals; 95% CI, −6.4 to 3.2; HR, 0.86; 95% CI, 0.71 to 1.05). Conclusions and Relevance: Among individuals diagnosed with ADHD, medication initiation was associated with significantly lower all-cause mortality, particularly for death due to unnatural causes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2024.0851

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 17

  1. Arrondo, 2022, Associations between mental and physical conditions in children and adolescents: an umbrella review., Neurosci Biobehav Rev, 137, 10.1016/j.neubiorev.2022.104662 · DOI · Paper page
  2. Du Rietz, 2021, Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study., Lancet Psychiatry, 8, 774, 10.1016/S2215-0366(21)00171-1 · DOI · Paper page
  3. Zhang, 2022, Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis., JAMA Netw Open, 5, 10.1001/jamanetworkopen.2022.43597 · DOI · Paper page
  4. Zhang, 2023, Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases., JAMA Psychiatry
  5. Chen, 2020, Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: population-based cohort study., Br J Psychiatry, 220, 1
  6. Stricker, 2022, General practice database on mortality in adults on methylphenidate: cohort study., BMJ Open, 12, 10.1136/bmjopen-2021-057303 · DOI
  7. Li, 2022, Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study., World Psychiatry, 21, 452, 10.1002/wps.v21.3 · doi:10.1002/wps.v21.3
  8. Hernán, 2022, Target trial emulation: a framework for causal inference from observational data., JAMA, 328, 2446, 10.1001/jama.2022.21383 · DOI · Paper page
  9. Khan, 2020, A review of measures used to examine medication adherence in people with ADHD at initiation, implementation and discontinuation of pharmacotherapy., Res Social Adm Pharm, 16, 277, 10.1016/j.sapharm.2019.06.001 · DOI
  10. Matthews, 2021, Comparing effect estimates in randomized trials and observational studies from the same population: an application to percutaneous coronary intervention., J Am Heart Assoc, 10, 10.1161/JAHA.120.020357 · DOI
  11. Maringe, 2020, Reflection on modern methods: trial emulation in the presence of immortal-time bias. assessing the benefit of major surgery for elderly lung cancer patients using observational data., Int J Epidemiol, 49, 1719, 10.1093/ije/dyaa057 · DOI · Paper page
  12. Cain, 2009, Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death., Stat Med, 28, 1725, 10.1002/sim.v28:12 · doi:10.1002/sim.v28:12
  13. Young, 2020, A causal framework for classical statistical estimands in failure-time settings with competing events., Stat Med, 39, 1199, 10.1002/sim.v39.8 · doi:10.1002/sim.v39.8
  14. Hallas, 2014, Use of self-controlled designs in pharmacoepidemiology., J Intern Med, 275, 581, 10.1111/joim.2014.275.issue-6 · doi:10.1111/joim.2014.275.issue-6
  15. Langan, 2018, The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)., BMJ, 363, k3532, 10.1136/bmj.k3532 · DOI · Paper page
  16. Liang, 2018, Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: a Taiwan nationwide population-based cohort study., Res Dev Disabil, 72, 96, 10.1016/j.ridd.2017.10.023 · DOI · Paper page
  17. Xu, 2019, Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis., Eur J Endocrinol, 180, 243, 10.1530/EJE-18-0792 · DOI · Paper page

Cited by

See all 124

Metadata

Authors
Li, L., Zhu, N., Zhang, L., Kuja-Halkola, R., D’Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z.
Venue
JAMA
Published
2024-03-12
Volume
331
Issue
10
Pages
850
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4392702193
Cited by
124
References
22
FWCI
33.38
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ADHD Pharmacotherapy and Mortality in Individuals With ADHD. https://app.cochat.ai/papers/10.1001/jama.2024.0851
The paper
Li, L., Zhu, N., Zhang, L., Kuja-Halkola, R., D’Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z. (2024). ADHD Pharmacotherapy and Mortality in Individuals With ADHD. JAMA. https://doi.org/10.1001/jama.2024.0851

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.